ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells

NCT06090864 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma
Relapse
Refractory

Interventions

DRUG: Chemotherapy
BIOLOGICAL: Cell infusion

Sponsor

UNC Lineberger Comprehensive Cancer Center